CareCloud (CCLD)
NASDAQ:CCLD
Top Page
CareCloud
(NASDAQ:CCLD)
Select Model
Select Model
Rating:75Outperform
Price Target:
$4.00
▲(29.87% Upside)
Action:ReiteratedDate:03/28/26
The score is driven primarily by strong recent cash generation, low leverage, and a meaningful profitability turnaround, reinforced by upbeat 2026 guidance. Offsetting these positives are a stretched valuation (very high P/E) and somewhat elevated near-term technical froth (overbought signals), with execution/integration and liquidity cushion as additional risks.
Positive Factors
Strong cash generation
Sustained operating cash flow growth and material free cash flow in 2025 provide durable funding for organic investment, R&D and disciplined M&A without equity dilution. That cash conversion lowers financing needs, supports reinvestment in AI/products and improves long-term financial flexibility.
Negative Factors
Historical profitability volatility
A pronounced negative swing in 2023 demonstrates that earnings and returns have been uneven historically. This volatility increases the risk that margins and cash generation could weaken again under reimbursement pressure, integration setbacks, or slower software adoption.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong cash generation
Sustained operating cash flow growth and material free cash flow in 2025 provide durable funding for organic investment, R&D and disciplined M&A without equity dilution. That cash conversion lowers financing needs, supports reinvestment in AI/products and improves long-term financial flexibility.
Read all positive factors
CareCloud (CCLD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$130.88M
Dividend YieldN/A
Average Volume (3M)575.34K
Price to Earnings (P/E)95.5
Beta (1Y)2.48
Revenue Growth2.97%
EPS GrowthN/A
CountryUS
Employees3,650
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.04
Shares Outstanding42,492,950
10 Day Avg. Volume543,056
30 Day Avg. Volume575,344
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)18.55
Price to Sales (P/S)9.16
P/FCF Ratio46.40
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue1.10
Enterprise Value/Gross Profit3.21
Enterprise Value/Ebitda4.68
Forecast
1Y Price Target
$5.63Price Target Upside82.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.14
Revenue Forecast (FY)$130.84M
CareCloud Business Overview & Revenue Model
Company Description
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcar...
How the Company Makes Money
CareCloud generates revenue primarily by selling healthcare software and by providing recurring, outsourced services to provider organizations. Key revenue streams include: (1) Subscription/SaaS and software-related revenue: recurring fees for acc...
CareCloud Earnings Call Summary
Earnings Call Date:Mar 12, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 20, 2026
Earnings Call Sentiment Positive
The call conveyed a strongly positive operational and financial narrative: meaningful revenue growth, the company's first full-year positive GAAP EPS since IPO, record adjusted EBITDA and materially improved cash generation funded disciplined M&A activity and the launch of an AI product suite with early customer traction. The main concerns discussed were short-term quarter variability (Q4 net income dip), modest cash on hand and the execution and integration risks tied to acquisitions and AI rollout amid broader AI/SaaS market uncertainty. On balance, the highlights (profitability, cash generation, strategic acquisitions, and early AI commercialization) substantially outweigh the lowlights.Positive Updates
Top-Line Growth
Full-year 2025 revenue of $120.5M, up ~9% year-over-year; Q4 2025 revenue $34.4M, up ~22% year-over-year; management raised revenue guidance twice during 2025 and still exceeded the final target.
Negative Updates
Quarterly Net Income Softness
Q4 2025 GAAP net income of $2.9M was down from $3.3M in Q4 2024, despite full-year improvement — indicating some short-term quarter-to-quarter variability.
Read all updates
Q4-2025 Updates
Positive
Negative
Top-Line Growth
Full-year 2025 revenue of $120.5M, up ~9% year-over-year; Q4 2025 revenue $34.4M, up ~22% year-over-year; management raised revenue guidance twice during 2025 and still exceeded the final target.
Read all positive updates
Company Guidance
CareCloud guided 2026 revenue of $128–$130 million, adjusted EBITDA of $29–$31 million (implying roughly 22.7%–23.8% EBITDA margin) and GAAP EPS of $0.20–$0.23 (more than 100% above 2025’s $0.10), noting the outlook does not include any unannounced material acquisitions and that CapEx/capitalized software spend should be roughly flat to slightly lower than 2025; for context, 2025 results were revenue $120.5M (~+9% YoY), Q4 revenue $34.4M (+~22% YoY, including ~$7.2M from Medsphere), GAAP net income $10.8M (+37% YoY), Q4 GAAP net income $2.9M (Q4 EPS $0.04), adjusted EBITDA $27.5M (23% margin), operating cash flow $28.6M (+38% YoY; Q4 $8.7M, +66%), free cash flow ~$20.5M (vs $13.2M in 2024), four 2025 acquisitions completed at <1x revenue, ~80% conversion of Series A preferred eliminating >$7M of annual dividends, and a $0 balance on the $10M credit line entering 2026.CareCloud Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
83
Very Positive
Cash Flow
86
Very Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.50M | 110.84M | 117.06M | 138.83M | 139.60M |
| Gross Profit | 41.08M | 49.99M | 46.24M | 54.39M | 52.68M |
| EBITDA | 28.84M | 25.05M | -31.29M | 21.02M | 19.70M |
| Net Income | 10.80M | 7.85M | -48.67M | 5.43M | 2.84M |
Balance Sheet | |||||
| Total Assets | 87.60M | 71.61M | 77.83M | 136.17M | 140.85M |
| Cash, Cash Equivalents and Short-Term Investments | 3.12M | 5.14M | 3.33M | 12.30M | 9.34M |
| Total Debt | 4.28M | 3.47M | 14.73M | 13.81M | 16.87M |
| Total Liabilities | 28.09M | 21.84M | 36.11M | 34.48M | 42.92M |
| Stockholders Equity | 59.51M | 49.77M | 41.72M | 101.69M | 97.93M |
Cash Flow | |||||
| Free Cash Flow | 23.78M | 18.95M | 3.85M | 9.38M | 2.77M |
| Operating Cash Flow | 28.56M | 20.64M | 15.46M | 21.15M | 13.33M |
| Investing Cash Flow | -24.54M | -7.41M | -11.61M | -11.77M | -23.15M |
| Financing Cash Flow | -5.61M | -11.26M | -13.29M | -7.65M | -519.00K |
CareCloud Technical Analysis
Neutral
3.08
Price Trends
2.87
Positive
2.96
Positive
2.97
Positive
Market Momentum
0.12
Positive
45.22
Neutral
5.29
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CCLD, the sentiment is Neutral. The current price of 3.08 is below the 20-day moving average (MA) of 3.40, above the 50-day MA of 2.87, and above the 200-day MA of 2.97, indicating a neutral trend. The MACD of 0.12 indicates Positive momentum. The RSI at 45.22 is Neutral, neither overbought nor oversold. The STOCH value of 5.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CCLD.
CareCloud Risk Analysis
CareCloud disclosed 72 risk factors in its most recent earnings report. CareCloud reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
CareCloud Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $130.88M | 95.53 | 18.98% | ― | 2.97% | ― | |
62 Neutral | $66.79M | -22.95 | -9.43% | ― | 42.60% | 67.76% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $94.51M | -0.82 | -35.88% | ― | 4.33% | 50.50% | |
44 Neutral | $48.89M | -3.85 | -571.06% | ― | ― | 4.31% |
* Healthcare Sector Average
CCLD
CareCloud
3.08
1.70
123.19%
AMWL
American Well
5.71
-1.46
-20.36%
FORA
Forian
2.14
0.26
13.83%
ONMD
OneMedNet
0.86
0.34
65.38%
BEAT
HeartBeam
1.19
-0.49
-29.17%
EUDA
EUDA Health Holdings
7.00
-63.20
-90.03%
CareCloud Corporate Events
Business Operations and StrategyExecutive/Board ChangesFinancial DisclosuresRegulatory Filings and Compliance
CareCloud Director Resignation Supports Nasdaq Governance Compliance
Neutral
Mar 12, 2026
On March 10, 2026, CareCloud, Inc. announced that director A. Hadi Chaudhry resigned from its Board of Directors, effective immediately, to help the company regain compliance with Nasdaq’s director independence rule requiring a majority-inde...
Dividends
CareCloud Declares Monthly Dividends on Preferred Stock
Positive
Jan 20, 2026
On January 20, 2026, CareCloud announced that its board had declared monthly cash dividends for its 8.75% Series A and Series B Cumulative Redeemable Perpetual Preferred Stock for January, February and March 2026, with per-share dividends of $0.18...
Business Operations and StrategyExecutive/Board Changes
CareCloud Announces Leadership Realignment to Advance AI Strategy
Positive
Dec 29, 2025
On December 29, 2025, CareCloud announced a leadership realignment effective January 1, 2026, with A. Hadi Chaudhry transitioning from Co-Chief Executive Officer to Chief Strategy Officer to lead the company’s enterprise AI vision and platfo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.